RHB PART
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

RHB PART Trademark

Serial Number: 79358374 • Registration: 7821159

RHB PART is a trademark filed by Richter-Helm BioLogics GmbH. & Co. KG on July 29, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Richter-Helm BioLogics GmbH. & Co. KG (2 trademarks)

Dengelsberg

Entity Type: 99

Trademark Details

Filing Date

July 29, 2022

Registration Date

June 10, 2025

Published for Opposition

May 21, 2024

Goods & Services

Biotechnological research; testing of biological reagents for use in molecular biology

Biological preparations for industrial use in manufacture; biological preparations for use in industry; nucleic recombinant acids, other than for medical and veterinary purposes

Biotechnological preparations for medical use for the treatment of infectious and parasitic diseases, neoplasms, cancer, diseases of the blood and blood-forming organs, immune disorders, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye, diseases of the ear, diseases of the cardiovascular, respiratory, genitourinary, and digestive systems, diseases and conditions of the skin and subcutaneous tissue and the musculoskeletal system and connective tissue, conditions relating to pregnancy, childbirth and the puerperium, conditions originating in the perinatal period, congenital malformations, deformations and chromosomal abnormalities, and poisoning; biotechnological preparations for medical purposes for the treatment of infectious and parasitic diseases, neoplasms, cancer, diseases of the blood and blood-forming organs, immune disorders, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye, diseases of the ear, diseases of the cardiovascular, respiratory, genitourinary, and digestive systems, diseases and conditions of the skin and subcutaneous tissue and the musculoskeletal system and connective tissue, conditions relating to pregnancy, childbirth and the puerperium, conditions originating in the perinatal period, congenital malformations, deformations and chromosomal abnormalities, and poisoning; biotechnological preparations, namely, nucleic recombinant acids for medical use

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 22, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 7, 2026 FICS
FINAL DISPOSITION PROCESSED
Jan 7, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 10, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 10, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 10, 2025 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 30, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 7, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 7, 2024 OPNR
NOTIFICATION PROCESSED BY IB
May 27, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 21, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 21, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 8, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 8, 2024 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 1, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 18, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 18, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 18, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 18, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 18, 2024 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 1, 2024 GNFN
FINAL REFUSAL E-MAILED
Feb 1, 2024 GNFR
FINAL REFUSAL WRITTEN
Feb 1, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 28, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 27, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 27, 2023 TROA
REFUSAL PROCESSED BY IB
Jul 26, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 6, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jul 6, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 26, 2023 RFCR
NON-FINAL ACTION WRITTEN
May 25, 2023 CNRT
ASSIGNED TO EXAMINER
May 17, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 31, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 27, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 22, 2022 REPR